NCT Number: NCT00035568
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Local Institution, Little Rock, Arkansas, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Adults 20-75 with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, and have an HbA1c greater than 6.7%
Treatment and study plan
or Metformin HCl alone
Drugor Glyburide alone.
DrugSponsors and collaborators
Lead sponsor
Bristol-Myers Squibb
Industry
Registry information
Important dates
- Study start
- 2002
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- May 6, 2002
- Registry last updated
- Apr 15, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Technology Intensified Diabetes Education Study in African Americans
NCT02088658
Diabetes Mellitus, Diabetes Mellitus, Adult-Onset
Charleston, South Carolina, United States
View Trial DetailsEvaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients
NCT02770235
Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent
Amiens, France
View Trial DetailsTelephone Delivered Behavioral Skills Intervention for Blacks With T2DM
NCT00929838
Diabetes Mellitus, Diabetes Mellitus, Adult-Onset
Charleston, South Carolina, United States
View Trial DetailsTranslating Healthy Lifestyle Interventions for Cancer Survivors
NCT02690766
Breast Cancer, Breast Diseases
View Trial Details